DTL
CLVS

Dynamic Technology Lab’s Clovis Oncology, Inc. CLVS Stock Holding History

Dynamic Technology Lab’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-38,990
Closed -$106K – 1659
2021
Q4 		$106K Buy
+38,990
New +$144K 0.01% 1031
2021
Q2 		– Sell
-11,703
Closed -$82K – 1674
2021
Q1 		$82K Buy
+11,703
New +$78.5K 0.01% 1071
2020
Q4 		– Sell
-22,879
Closed -$133K – 1457
2020
Q3 		$133K Buy
+22,879
New +$137K 0.02% 867

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Dynamic Technology Lab's CLVS Position: Q1 2022 in Review

Dynamic Technology Lab sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 38,990 shares — an estimated $106K sold.

Dynamic Technology Lab first reported a position in CLVS in Q3 2020 and held it in 3 quarters. The position peaked at $133K in Q3 2020. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • Dynamic Technology Lab reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • Dynamic Technology Lab sold 38,990 Clovis Oncology, Inc. shares in Q1 2022, an estimated $106K.
  • Dynamic Technology Lab first reported a position in Clovis Oncology, Inc. in Q3 2020 and held it in 3 quarters.
  • Dynamic Technology Lab's Clovis Oncology, Inc. position peaked at $133K in Q3 2020.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on Dynamic Technology Lab's 13F filing for Q1 2022, filed 16 May 2022.